Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.
Publication
, Journal Article
Lee, WR
Published in: Brachytherapy
2019
Duke Scholars
Published In
Brachytherapy
DOI
EISSN
1873-1449
Publication Date
2019
Volume
18
Issue
3
Start / End Page
426
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Oncology & Carcinogenesis
- Male
- Humans
- Brachytherapy
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, W. R. (2019). Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results. Brachytherapy, 18(3), 426. https://doi.org/10.1016/j.brachy.2019.01.009
Lee, W Robert. “Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.” Brachytherapy 18, no. 3 (2019): 426. https://doi.org/10.1016/j.brachy.2019.01.009.
Lee, W. Robert. “Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.” Brachytherapy, vol. 18, no. 3, 2019, p. 426. Pubmed, doi:10.1016/j.brachy.2019.01.009.
Published In
Brachytherapy
DOI
EISSN
1873-1449
Publication Date
2019
Volume
18
Issue
3
Start / End Page
426
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Oncology & Carcinogenesis
- Male
- Humans
- Brachytherapy
- 3202 Clinical sciences
- 1103 Clinical Sciences